CLOZAPINE AS A TREATMENT FOR PSYCHOSIS IN PARKINSONS-DISEASE - A REVIEW

Authors
Citation
Ws. Musser et M. Akil, CLOZAPINE AS A TREATMENT FOR PSYCHOSIS IN PARKINSONS-DISEASE - A REVIEW, The Journal of neuropsychiatry and clinical neurosciences, 8(1), 1996, pp. 1-9
Citations number
52
Categorie Soggetti
Neurosciences,"Clinical Neurology",Psychiatry
ISSN journal
08950172
Volume
8
Issue
1
Year of publication
1996
Pages
1 - 9
Database
ISI
SICI code
0895-0172(1996)8:1<1:CAATFP>2.0.ZU;2-N
Abstract
Psychotic symptoms such as visual hallucinations and delusions are a r elatively common clinical problem in patients with Parkinson's disease (PD). A dilemma arises in the treatment of psychosis in these patient s because traditional antipsychotics are dopaminergic antagonists that worsen the motor symptoms of PD. Clozapine, an atypical antipsychotic , has been successfully used in the treatment of psychosis in PD patie nts. The use of clozapine in these patients differs significantly, how ever, from its use in young, relatively healthy, treatment-resistant s chizophrenic patients in the dosage required, side effects, and other aspects of management.